UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 90

Sortiert nach

KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges

Pathology oncology research, 2024-01, Vol.29, p.1611580-1611580

2024

Link zum Volltext

Verfügbarkeit prüfen

Are tumor-associated carbohydrates the missing link between the gut microbiome and response to immune checkpoint inhibitor treatment in cancer?

Oncoimmunology, 2024, Vol.13 (1), p.2324493-2324493

2024

Link zum Volltext

Verfügbarkeit prüfen

Afatinib restrains K-RAS-driven lung tumorigenesis

Science translational medicine, 2018-06, Vol.10 (446)

2018

Link zum Volltext

Verfügbarkeit prüfen

Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study

Scientific reports, 2023-04, Vol.13 (1), p.6268-6268, Article 6268

2023

Link zum Volltext

Verfügbarkeit prüfen

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

NPJ precision oncology, 2021-06, Vol.5 (1), p.55-55, Article 55

2021

Link zum Volltext

Verfügbarkeit prüfen

Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma

Pathology oncology research, 2023-08, Vol.29, p.1611328-1611328

2023

Link zum Volltext

Verfügbarkeit prüfen

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma

Journal of thoracic oncology, 2015-05, Vol.10 (5), p.738-746

2015

Link zum Volltext

Verfügbarkeit prüfen

Applied models and molecular characteristics of small cell lung cancer

Pathology oncology research, 2024-04, Vol.30, p.1611743-1611743

2024

Link zum Volltext

Verfügbarkeit prüfen

Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations

Frontiers in oncology, 2021-06, Vol.11, p.644592-644592

2021

Link zum Volltext

Verfügbarkeit prüfen

PD-1 and PD-L1 expression in rare lung tumors

Pathology oncology research, 2023-05, Vol.29, p.1611164-1611164

2023

Link zum Volltext

Verfügbarkeit prüfen

The landscape of small cell lung cancer metastases: Organ specificity and timing

Thoracic cancer, 2021-03, Vol.12 (6), p.914-923

2021

Link zum Volltext

Verfügbarkeit prüfen

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic

Frontiers in oncology, 2023-10, Vol.13, p.1207295-1207295

2023

Link zum Volltext

Verfügbarkeit prüfen

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary

Frontiers in oncology, 2019-10, Vol.9, p.1051-1051

2019

Link zum Volltext

Verfügbarkeit prüfen

Application of a Receptor-Binding-Domain-Based Simple Immunoassay for Assessing Humoral Immunity against Emerging SARS-CoV-2 Virus Variants

Biomedicines, 2023-12, Vol.11 (12), p.3193

2023

Link zum Volltext

Verfügbarkeit prüfen

Wnt Activity and Cell Proliferation Are Coupled to Extracellular Vesicle Release in Multiple Organoid Models

Frontiers in cell and developmental biology, 2021-06, Vol.9, p.670825-670825

2021

Link zum Volltext

Verfügbarkeit prüfen

Distinct claudin expression profile in histologic subtypes of lung cancer

Lung cancer (Amsterdam, Netherlands), 2007-08, Vol.57 (2), p.159-167

2007

Link zum Volltext

Verfügbarkeit prüfen

The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas

Pathology oncology research, 2004-01, Vol.10 (2), p.85-88

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract PO-046: LKB1 loss-associated changes in histone acetylation are potential therapeutic targets in lung adenocarcinoma

Cancer research (Chicago, Ill.), 2020-12, Vol.80 (23_Supplement), p.PO-046-PO-046

2020

Link zum Volltext

Verfügbarkeit prüfen

NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates

European journal of heart failure, 2004-10, Vol.6 (6), p.753-756

2004

Link zum Volltext

Verfügbarkeit prüfen

JAK–STAT inhibition impairs K‐RAS‐driven lung adenocarcinoma progression

International journal of cancer, 2019-12, Vol.145 (12), p.3376-3388

2019

Link zum Volltext

Verfügbarkeit prüfen

Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives

Journal of proteome research, 2021-01, Vol.20 (1), p.1027-1039

2021

Link zum Volltext

Verfügbarkeit prüfen

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

Scientific reports, 2017-01, Vol.7 (1), p.39721-39721, Article 39721

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 90

Suche als RSS-Feed

Aktive Filter

ThemaPatients

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(90)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Humans
(50)
Life Sciences & Biomedicine
(50)
Oncology
(40)
Female
(25)
Lung Cancer
(25)
Male
(24)
Middle Aged
(23)
Aged
(21)
Lung Neoplasms - Pathology
(20)
Pathology
(19)
Immunohistochemistry
(17)
Adult
(16)
Lung Neoplasms - Drug Therapy
(14)
Lung Neoplasms - Genetics
(14)
Lung Adenocarcinoma
(13)
Mutation
(12)
Hungary
(10)
Retrospective Studies
(10)
Antineoplastic Agents - Therapeutic Use
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges

Are tumor-associated carbohydrates the missing link between the gut microbiome and response to immune checkpoint inhibitor treatment in cancer?

Afatinib restrains K-RAS-driven lung tumorigenesis

Inter- and intratumoral proteomics and glycosaminoglycan characterization of ALK rearranged lung adenocarcinoma tissues: a pilot study

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma

Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma

Applied models and molecular characteristics of small cell lung cancer

Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations

PD-1 and PD-L1 expression in rare lung tumors

Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources

The landscape of small cell lung cancer metastases: Organ specificity and timing

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

Application of a Receptor-Binding-Domain-Based Simple Immunoassay for Assessing Humoral Immunity against Emerging SARS-CoV-2 Virus Variants

Wnt Activity and Cell Proliferation Are Coupled to Extracellular Vesicle Release in Multiple Organoid Models

Distinct claudin expression profile in histologic subtypes of lung cancer

The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas

Abstract PO-046: LKB1 loss-associated changes in histone acetylation are potential therapeutic targets in lung adenocarcinoma

NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates

JAK–STAT inhibition impairs K‐RAS‐driven lung adenocarcinoma progression

Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study

Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

Aktive Filter

Suchergebnisse filtern